Roy Amariglio

Overview

Roy Amariglio serves as a Principal at OrbiMed [1][2]. Amariglio holds a Doctor of Philosophy in Molecular Genetics from the Weizmann Institute of Science [9], where Amariglio worked as a Researcher and PhD Student from 2005 to 2009 [6]. Amariglio also earned an MBA in Health Care Management from The Wharton School between 2009 and 2011 [8], and completed a B.Sc in Biology at Tel Aviv University [10]. Prior to the current role at OrbiMed, Amariglio worked as Director of Global Business Development at Bayer HealthCare from 2013 to 2016 [3], and as Senior Consultant at the same company from 2011 to 2013 [4]. Amariglio also held positions as an Associate at Market Bridges [7] and as a Summer Associate in Corporate Development and Mergers & Acquisitions at Life Technologies [5].

Career history

1. PrincipalMay 2016 to presentOrbiMed
2. BHDirector Global Business DevelopmentJun 2013 to May 2016Bayer HealthCare
3. BHSenior ConsultantJun 2011 to Jun 2013Bayer HealthCare
4. LTSummer Associate, Corporate Development, Mergers & AcquisitionsJun 2010 to Aug 2010Life Technologies
5. WIResearcher, PhD StudentJan 2005 to Aug 2009Weizmann Institute of Science
6. MBAssociateMar 2007 to Mar 2009Market Bridges

Education

1. MBA, Health Care Management2009 - 2011The Wharton School
2. WIDoctor of Philosophy (PhD), Molecular Genetics2003 - 2009Weizmann Institute of Science
3. B.Sc, Biology1998 - 2001Tel Aviv University